Abstract:A dual-response (near-infrared, alternating magnetic field) multifunctional nanoplatform was developed based on urokinase plasminogen activators (uPA)-loaded metal–organic-framework (MOF)-derived carbon nanomaterials (referred to below) for thrombolytic therapy. uPA loaded in mesoporous CFs could be released under the action of near-infrared (NIR)-mediated photothermy to achieve superficial thrombolysis. More importantly, with the assistance of alternating magnetic field (AMF), this system could also precisely heat the thrombosis in the deep tissue area. Quantitative experiments proved that the thrombolytic efficiency of this dual-response system at deep venous thrombosis was nearly 6 times than that of NIR alone. This is the first application that MOF-derived carbon nanomaterials in the field of targeted thrombolysis. To our delight, the MOF-derived carbon nanomaterials (CFs) not only maintained the drug-carrying capacity, but also endowed CFs with reliable magnetic targeting ability. More encouragingly, the CFs also showed extraordinary angiogenic performance, thus opening up the prospect of its clinical application.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c03134?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c03134</a>.Particle size distribution of CFs (Figure S1a). Stability of the CFs hydrodynamic size during different incubation periods with serum (Figure S1b). High-resolution XPS spectra of (a) Fe 2p, (b) O 1s, and (c) C 1s (Figure S2). The summary of nitrogen adsorption–desorption analysis of MOFs (Fe) and CFs samples (Table S1). Pore size distribution of (a) MOFs (Fe) and (b) CFs samples (Figure S3). VSM curve of at room temperature (Figure S4). The photothermal effect and magnetothermal effect of CFs (Figure S5). uPA release from after being placed in saline over 7 days (Figure S6). The thickness of pork (Figure S7a). Deep evaluation of the magnetic field attracting CFs using different thickness of pork (scale bar = 1 cm) (Figure S7b). SEM analysis of thrombolysis (scale bar = 2 μm) (Figure S8). Scanning electron microscopy (SEM) images and the elemental mapping data of the degradation of CFs at the thrombus site at (a) 20 min, (b) 40 min, and (c) 1 h (scale bar = 5 μm) (Figure S9). SEM images of RBCs treated with different concentrations of CFs (scale bar = 5 μm) (Figure S10). Cell viability of HSF and HUVECs treated with different concentrations of CFs for 24 h (Figure S11a). Cell viability with various concentrations of CFs, CFs + NIR, CFs + AMF for 12 and 48 h (Figure S11b). Cell viability of HUVECs cocultured with different concentrations of CFs and VEGF for various time as indicated above. (Error bars represent the standard deviation of six separate measurements) (Figure S12). Photos (clots are marked in blue circles, scale bar = 1 cm) of clots before and after treatment for 24 h (Figure S13). The amount of Fe in the major organs and blood after treatment for 7 days (Figure S14). Four indicators of coagulation in SD rats (Figure S15a). Some indexes of liver and kidney function in SD rats (Figure S15b). The average body weight of rats in each group during the treatment periods (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c03134/suppl_file/am1c03134_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Dual Drive Mode Polydopamine Nanomotors for Continuous Treatment of an Inferior Vena Cava Thrombus

Nitric Oxide-Driven Nanomotors with Bowl-Shaped Mesoporous Silica for Targeted Thrombolysis.

Targeting Nanomotor with Near‐Infrared/Ultrasound Triggered‐Transformation for Polystage‐Propelled Cascade Thrombolysis and Multimodal Imaging Diagnosis

Near-infrared light-driven multifunctional metal ion (Cu2+)-loaded polydopamine nanomotors for therapeutic angiogenesis in critical limb ischemia

Dual-mode nanoprobe strategy integrating ultrasound and near-infrared light for targeted and synergistic arterial thrombolysis

Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C-Shaped Magnetic Actuation System In Vivo

Biological Mediator-Propelled Nanosweeper for Nonpharmaceutical Thrombus Therapy

Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation

Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis

Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration

Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy

pH-Responsive theranostic colloidosome drug carriers enable real-time imaging of targeted thrombolytic process with near-infrared-II for deep venous thrombosis

Targeted Thrombolytic Therapy with Metal–Organic-Framework-Derived Carbon Based Platforms with Multimodal Capabilities

Controllable Thrombolysis Using a Nanobubble-Imaging-Guided Rtpa Targeted Delivery Strategy

Platelet-Mimic Upa Delivery Nanovectors Based on Au Rods for Thrombus Targeting and Treatment.

Accelerating Thrombolysis of Arterial Thrombus with NO-MBs UTMD Therapy

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy

Thrombus Targeted Delivery of Urokinase and Ticagrelor for Thrombosis-related Diseases Treatment

Platelet Membrane Biomimetic Magnetic Nanocarriers for Targeted Delivery and in Situ Generation of Nitric Oxide in Early Ischemic Stroke.